Axios @axios
NEW: The promises from buzzy health tech startup Olive don't deliver, an Axios investigation finds. Olive relies on rough estimations for its calculations, inflates its capabilities and in many cases, generates only a fraction of the savings it pledges. https://t.co/wYfPEwjkcZ — PolitiTweet.org